A citation-based method for searching scientific literature

C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
Times Cited: 139







List of co-cited articles
579 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
45

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
44

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
434
29

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
243
26


Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
432
22

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
20

Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
127
18

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
18


Attitudes toward colon cancer gene testing: factors predicting test uptake.
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
123
18

Mammography adherence and psychological distress among women at risk for breast cancer.
C Lerman, M Daly, C Sands, A Balshem, E Lustbader, T Heggan, L Goldstein, J James, P Engstrom. J Natl Cancer Inst 1993
352
17

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
276
17


Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
92
18

Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
349
16


Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
92
16

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
263
15

Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
175
15


Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
145
14

Psychological impact of receiving a BRCA1/BRCA2 test result.
L Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, A M van den Ouweland,[...]. Am J Med Genet 2001
116
14

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
184
13

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
13

Looking forward and back: distress among women at familial risk for breast cancer.
J Erblich, D H Bovbjerg, H B Valdimarsdottir. Ann Behav Med 2000
94
12

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
C Lerman, C Hughes, R T Croyle, D Main, C Durham, C Snyder, A Bonney, J F Lynch, S A Narod, H T Lynch. Prev Med 2000
186
12

Stress and genetic testing for disease risk.
A Baum, A L Friedman, S G Zakowski. Health Psychol 1997
97
12

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.
C Foster, D G R Evans, R Eeles, D Eccles, S Ashley, L Brooks, T Cole, J Cook, R Davidson, H Gregory,[...]. Genet Test 2004
49
24

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
11

Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer.
S G Zakowski, H B Valdimarsdottir, D H Bovbjerg, P Borgen, J Holland, K Kash, D Miller, J Mitnick, M Osborne, K Van Zee. Ann Behav Med 1997
109
11


Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
241
11

Motivations and psychosocial impact of genetic testing for HNPCC.
M J Esplen, L Madlensky, K Butler, W McKinnon, B Bapat, J Wong, M Aronson, S Gallinger. Am J Med Genet 2001
74
14

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
10




Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
M Dorval, A F Patenaude, K A Schneider, S A Kieffer, L DiGianni, K J Kalkbrenner, J I Bromberg, L A Basili, K Calzone, J Stopfer,[...]. J Clin Oncol 2000
100
10

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
225
10

Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families.
J C Coyne, N R Benazon, C G Gaba, K Calzone, B L Weber. J Consult Clin Psychol 2000
92
10

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
L N Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, P Devilee,[...]. J Med Genet 1999
60
15

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
9

Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
128
9

Intention to learn results of genetic testing for hereditary colon cancer.
S W Vernon, E R Gritz, S K Peterson, C A Perz, S Marani, C I Amos, W F Baile. Cancer Epidemiol Biomarkers Prev 1999
74
12




Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.